MYH9-ORAOV1 Fusion FISH Probe
The MYH9-ORAOV1 Fusion FISH Probe is used to confirm a fusion of the MYH9 and ORAOV1 genes. The fusion of the MYH9 and ORAOV1 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
MYH9-ORAOV1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-RERE | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-REOR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-REGO | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-REGR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-REAQ | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-ORRE | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-OROR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-ORGO | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-ORAQ | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GORE | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GOOR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GOGO | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GOGR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GOAQ | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GRRE | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GROR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GRGO | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GRGR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-GRAQ | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-AQRE | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-AQOR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-AQGO | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-AQGR | 20 (40 μL) | 200 μL | ||
MYH9-ORAOV1-20-AQAQ | 20 (40 μL) | 200 μL |
MYH9 Gene Summary
This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
Gene Name: Myosin Heavy Chain 9
Chromosome: CHR22: 36677322 -36784063
Locus: 22q12.3
ORAOV1 Gene Summary
The Oral Cancer Overexpressed 1 (ORAOV1) gene is located on chr11 :69480331-69490165 at 11q13.3.
Gene Name: Oral Cancer Overexpressed 1
Chromosome: CHR11: 69480331 -69490165
Locus: 11q13.3
Gene Diseases
The MYH9 ORAOV1 Fusion has been associated with the following diseases:
Disease Name |
---|
Lung Adenocarcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|